| Financial Year |
March 31 2023 |
| Monetary Funds |
3,333,890,378.07 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
243,377,448.28 |
| Advances to Suppliers |
768,919,108.42 |
| Other Receivables |
95,719,644.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,170,115,190.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
114,022,073.78 |
| Total Current Assets |
6,249,673,101.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
568,000.00 |
| Long-term Equity Investment |
1,756,355,242.34 |
| Investment Properties |
264,656,048.23 |
| Fixed Assetes |
4,169,938,398.41 |
| Under-construction Projects |
594,407,913.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,207,868,242.96 |
| R&D expenses |
17,151,806.72 |
| Goodwill |
1,235,254,087.51 |
| Long-Term Deferred and Prepaid Expenses |
18,720,986.97 |
| Deferred Income Tax Assets |
120,521,661.59 |
| Other Non-Current Assets |
67,125,558.72 |
| Sub-Total of Non-Current Assets |
10,827,543,682.89 |
| Total Assets |
17,077,216,784.75 |
| Short-Term Loans |
1,173,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
598,071,889.30 |
| Accounts Payable |
814,112,786.46 |
| Accounts Received In Advance |
112,616,638.15 |
| Employee Compensation Payable |
150,296,945.18 |
| Taxes Payable |
128,553,732.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
355,318,379.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
636,597.75 |
| Other Current Liabilities |
16,696,691.23 |
| Sub-Total of Current Liabilities |
3,622,472,395.94 |
| Long-term Loans |
3,367,776,700.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
480,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
36,202,715.55 |
| Deferred Income Tax Liabilities |
266,547,188.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,162,457,321.57 |
| Total Liabilities |
7,784,929,717.51 |
| Paid-In Capital(Or Share Stock) |
1,892,131,394.00 |
| Capital Surplus |
5,662,480,374.75 |
| Surplus Reserve |
118,327,368.55 |
| LESS:Treasury Stock |
103,103,162.50 |
| Undistributed Profits |
1,683,510,862.34 |
| Minority Stockholder's Interest |
10,674,532.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,281,612,534.79 |
| Owner's Equity（Stockholder's Equity） |
9,292,287,067.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,077,216,784.75 |
